AndroGel Generic Settlement Focuses On Co-Promotion Deals
This article was originally published in The Pink Sheet Daily
Watson and Par will promote Solvay’s testosterone gel until their respective generics launch.
You may also be interested in...
FTC seeking information on four deals that postpone generic entry.
Valeant will also study the cannabinoid-receptor agonist in combination with other anti-emetics.
Bristol's conduct relating to the settlement with Apotex was "appropriate," CEO Dolan maintains.